Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

MIXED(2)

Rituximab

1 trial

phase_1

national-institute-of-allergy-and-infectious-diseases-niaid

Infliximab

1 trial

phase_2

national-institute-of-allergy-and-infectious-diseases-niaid

2 unique interventions1 categories

Analytics

Trial Phases

Phase 11

Phase 21

Trial Status

Completed2

Role Distribution

Principal Investigator1

Other Roles1

PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT00101829Phase 1Completed

Anti-CD20 Antibody Therapy for Sjogren's Syndrome

Sjogren's Syndrome

Principalinvestigator

NCT00283712Phase 2Completed

Use of Infliximab for the Treatment of Pemphigus Vulgaris

Pemphigus

Studychair

Research Network

Collaboration Network

7 collaborators·16 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Pemphigus1 Sjogren's Syndrome1

Affiliations

Division of Rheumatology and Immunology, Duke University Medical Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Tsan-Teng Ou, MD

Kaohsiung Medical University

1 trials

Shared therapeutic areas:

Sjogren's Syndrome

Similarity Score15%

Andrew McGovern, MD

Momentum Data

5 trials

Shared therapeutic areas:

Sjogren's Syndrome

Similarity Score15%

Zhaohui Zhu, MD

Peking Union Medical College Hospital

19 trials

Shared therapeutic areas:

Sjogren's Syndrome

Similarity Score15%

Daniel Brocks, MD

Boston Sight

4 trials

Shared therapeutic areas:

Sjogren's Syndrome

Similarity Score15%

Faida Ajili, MD

Military Hospital of Tunis

2 trials

Shared therapeutic areas:

Sjogren's Syndrome

Similarity Score15%

He Huang, PhD

First Affiliated Hospital of Zhejiang University

11 trials

Shared therapeutic areas:

Sjogren's Syndrome

Similarity Score15%

Wan-Yu Sung, MD

Kaohsiung Medical University

1 trials

Shared therapeutic areas:

Sjogren's Syndrome

Similarity Score15%

Huji Xu, Ph.D, MD

Shanghai Changzheng Hospital

3 trials

Shared therapeutic areas:

Sjogren's Syndrome

Similarity Score15%

Philippe GUILPAIN, MD, PhD

University Hospital, Montpellier

3 trials

Shared therapeutic areas:

Sjogren's Syndrome

Similarity Score15%

Zhanguo Li

Peking University Institute of Rheuamotology and Immunology

9 trials

Shared therapeutic areas:

Sjogren's Syndrome

Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00101829Phase 1PrincipalInvestigator

Anti-CD20 Antibody Therapy for Sjogren's Syndrome

Sjogren's Syndrome

Completed

NCT00283712Phase 2StudyChair

Use of Infliximab for the Treatment of Pemphigus Vulgaris

Pemphigus

Completed

All 2 trials loaded